Influenza Vaccine Sales Market will reach 5270 million US$ by the end of 2025

This report studies the global Influenza Vaccine market status and forecast, categorizes the global Influenza Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes.

The global Influenza Vaccine market is valued at 3090 million US$ in 2017 and will reach 5270 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/59564/global-influenza-vaccine-sales-market

The major players covered in this report

    AstraZeneca

    CSL

    GlaxoSmithKline

    Sanofi

    Altimmune

    BionVax

    FluGen

    FOLIA BIOTECH

    Genentech

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

    Trivalent

    Quadrivalent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

    Adults

    Pediatrics

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/59564/global-influenza-vaccine-sales-market